Kodiak Sciences Inc.

08/08/2022 | Press release | Distributed by Public on 08/08/2022 04:33

Kodiak Sciences Reports Positive Topline Results from BEACON Phase 3 Study of Tarcocimab Tedromer (KSI-301) in Patients with Retinal Vein Occlusion